PROSPECT SURGERY
20 CLEVELAND SQUARE, CLEVELAND CENTRE, MIDDLESBROUGH
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 165 | 208 | 79.3% | |
| CKD 4 | 2008 | 187 | 221 | 84.6% | |
| CKD 5 | 2009 | 36 | 42 | 85.7% | |
| CKD 5 | 2010 | 38 | 41 | 92.7% | |
| CKD 5 | 2011 | 34 | 39 | 87.2% | |
| CKD 5 | 2012 | 38 | 39 | 97.4% | |
| CKD 5 | 2013 | 35 | 37 | 94.6% | |
| CKD003 | 2014 | 30 | 30 | 100.0% | |
| CKD003 | 2015 | 26 | 27 | 96.3% | |
| NM84 | 2016 | 25 | 35 | 71.4% | |
| NM84 | 2017 | 22 | 32 | 68.8% | |
| NM84 | 2018 | 21 | 29 | 72.4% | |
| NM84 | 2019 | 18 | 26 | 69.2% | |
| NM84 | 2020 | 20 | 26 | 76.9% | |
| NM84 | 2022 | 20 | 30 | 66.7% | |
| NM84 | 2023 | 18 | 31 | 58.1% |
